We provide an integrated solution to enable the assertive entry strategy of advanced and affordable medicines, medical devices, dermo-cosmetics and health products into the brazilian life sciences market.
If your company is considering the insertion of your portfolio and pipeline of products in the high potential Life Sciences Market represented by the Brazilian Country, Zalika Farmacêutica must be your local partner in Brazil!
Conceiving tailored projects, Zalika will support your company in all stages of the Market Entry Strategy.
A Índia como um todo é responsável por mais de 60% das vacinas vendidas mundialmente. O instituto é o maior fabricante de vacinas do planeta por número de doses: produz 1,5 bilhão por ano. O Instituto Serum, da Índia, é o maior fabricante de vacinas do planeta por número de doses e deve ter papel… See more »
NEW DELHI: Serum Institute of India (SII) may get emergency use approval for Covishield in India soon after the UK’s drug regulator MHRA gives a nod to the vaccine, which officials here expect to be before Christmas. The Medicines and Healthcare Products Regulatory Agency (MHRA) is currently evaluating data including which dosing regimen is best… See more »